Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-066987
Filing Date
2025-05-08
Accepted
2025-05-08 16:15:17
Documents
50
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alec-20250331.htm   iXBRL 10-Q 1835974
2 EX-10.1 alec-ex10_1.htm EX-10.1 52024
3 EX-31.1 alec-ex31_1.htm EX-31.1 22454
4 EX-31.2 alec-ex31_2.htm EX-31.2 22451
5 EX-32.1 alec-ex32_1.htm EX-32.1 9479
6 EX-32.2 alec-ex32_2.htm EX-32.2 9458
  Complete submission text file 0000950170-25-066987.txt   5602779

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alec-20250331.xsd EX-101.SCH 616892
53 EXTRACTED XBRL INSTANCE DOCUMENT alec-20250331_htm.xml XML 762203
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38792 | Film No.: 25926300
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)